25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cathay Biotech Inc
Buy, Hold or Sell?

Let's analyze Cathay Biotech Inc together

I guess you are interested in Cathay Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cathay Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cathay Biotech Inc

I send you an email if I find something interesting about Cathay Biotech Inc.

1. Quick Overview

1.1. Quick analysis of Cathay Biotech Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cathay Biotech Inc? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥25.69
Expected worth in 1 year
¥25.22
How sure are you?
81.8%

+ What do you gain per year?

Total Gains per Share
¥-0.23
Return On Investment
-0.5%

For what price can you sell your share?

Current Price per Share
¥43.10
Expected price per share
¥36.69 - ¥56.98
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cathay Biotech Inc (5 min.)




Live pricePrice per Share (EOD)
¥43.10

2.2. Growth of Cathay Biotech Inc (5 min.)




Is Cathay Biotech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$2b$2b-$37.6m-1.8%

How much money is Cathay Biotech Inc making?

Current yearPrevious yearGrowGrow %
Making money$13.6m$13m$577.8k4.2%
Net Profit Margin14.1%17.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Cathay Biotech Inc (5 min.)




2.4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cathay Biotech Inc?

Welcome investor! Cathay Biotech Inc's management wants to use your money to grow the business. In return you get a share of Cathay Biotech Inc.

First you should know what it really means to hold a share of Cathay Biotech Inc. And how you can make/lose money.

Speculation

The Price per Share of Cathay Biotech Inc is ¥43.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cathay Biotech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cathay Biotech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥25.69. Based on the TTM, the Book Value Change Per Share is ¥-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cathay Biotech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.020.1%0.020.1%0.030.1%0.030.1%
Usd Book Value Change Per Share0.020.1%-0.020.0%0.020.0%0.320.7%0.320.7%
Usd Dividend Per Share0.030.1%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.050.1%-0.010.0%0.030.1%0.330.8%0.330.8%
Usd Price Per Share6.52-6.59-8.26-8.90-8.90-
Price to Earnings Ratio70.94-82.75-112.90-93.91-93.91-
Price-to-Total Gains Ratio130.66-287.36-355.06-133.22-133.22-
Price to Book Ratio1.85-1.88-2.32-2.53-2.53-
Price-to-Total Gains Ratio130.66-287.36-355.06-133.22-133.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.91332
Number of shares169
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.020.32
Usd Total Gains Per Share-0.010.33
Gains per Quarter (169 shares)-1.3655.87
Gains per Year (169 shares)-5.45223.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16-11-157217213
211-22-2014433436
317-33-2521650659
422-44-3027867882
528-55-353410831105
634-66-404113001328
739-77-454815161551
845-88-505517331774
950-99-556219501997
1056-110-606921662220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.02.00.081.8%9.02.00.081.8%9.02.00.081.8%9.02.00.081.8%
Dividend per Share4.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share3.01.00.075.0%9.02.00.081.8%9.02.00.081.8%9.02.00.081.8%9.02.00.081.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cathay Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.169-0.119+170%0.134+26%2.336-93%2.336-93%
Book Value Per Share--25.69425.505+1%25.975-1%25.680+0%25.680+0%
Current Ratio--2.8692.617+10%4.194-32%4.977-42%4.977-42%
Debt To Asset Ratio--0.1820.197-7%0.173+5%0.165+10%0.165+10%
Debt To Equity Ratio--0.2930.324-9%0.287+2%0.270+9%0.270+9%
Dividend Per Share--0.1950.060+224%0.057+240%0.074+164%0.074+164%
Enterprise Value--24392940221.48024362672872.453+0%31940489215.678-24%34855985082.137-30%34855985082.137-30%
Eps--0.1680.170-2%0.163+3%0.197-15%0.197-15%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--7.9129.073-13%14.787-46%14.461-45%14.461-45%
Free Cash Flow Per Share--0.276-0.067+124%-0.649+335%-0.680+346%-0.680+346%
Free Cash Flow To Equity Per Share--0.276-0.067+124%-0.649+335%-0.680+346%-0.680+346%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap25143591110.400-10%27733791974.06028009438097.488-1%35116438510.280-21%37857509387.225-27%37857509387.225-27%
Net Profit Margin--0.1270.141-10%0.178-29%0.188-33%0.188-33%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.4851.533-3%1.561-5%1.520-2%1.520-2%
Pb Ratio1.677-10%1.8501.883-2%2.318-20%2.529-27%2.529-27%
Pe Ratio64.318-10%70.94482.748-14%112.896-37%93.909-24%93.909-24%
Price Per Share43.100-10%47.54048.013-1%60.195-21%64.894-27%64.894-27%
Price To Free Cash Flow Ratio38.975-10%42.9907.615+465%-77.094+279%-29.409+168%-29.409+168%
Price To Total Gains Ratio118.461-10%130.664287.360-55%355.058-63%133.218-2%133.218-2%
Quick Ratio--0.1320.109+22%0.170-22%0.190-30%0.190-30%
Return On Assets--0.0050.005-1%0.005+3%0.006-18%0.006-18%
Return On Equity--0.0090.009-3%0.0090%0.010-18%0.010-18%
Total Gains Per Share--0.364-0.059+116%0.191+90%2.410-85%2.410-85%
Usd Book Value--2056516079.1212041425691.876+1%2079049361.055-1%2055405805.771+0%2055405805.771+0%
Usd Book Value Change Per Share--0.023-0.016+170%0.018+26%0.320-93%0.320-93%
Usd Book Value Per Share--3.5253.499+1%3.564-1%3.523+0%3.523+0%
Usd Dividend Per Share--0.0270.008+224%0.008+240%0.010+164%0.010+164%
Usd Enterprise Value--3346711398.3873342558718.100+0%4382235120.391-24%4782241153.269-30%4782241153.269-30%
Usd Eps--0.0230.023-2%0.022+3%0.027-15%0.027-15%
Usd Free Cash Flow--22127545.014-5399303.590+124%-51967032.576+335%-54417830.423+346%-54417830.423+346%
Usd Free Cash Flow Per Share--0.038-0.009+124%-0.089+335%-0.093+346%-0.093+346%
Usd Free Cash Flow To Equity Per Share--0.038-0.009+124%-0.089+335%-0.093+346%-0.093+346%
Usd Market Cap3449700700.347-10%3805076258.8413842894906.975-1%4817975363.610-21%5194050287.927-27%5194050287.927-27%
Usd Price Per Share5.913-10%6.5226.587-1%8.259-21%8.903-27%8.903-27%
Usd Profit--13408804.39813645108.989-2%13067286.658+3%15777597.663-15%15777597.663-15%
Usd Revenue--105752442.62194797249.481+12%74392300.779+42%84444881.216+25%84444881.216+25%
Usd Total Gains Per Share--0.050-0.008+116%0.026+90%0.331-85%0.331-85%
 EOD+4 -4MRQTTM+25 -12YOY+20 -175Y+15 -2210Y+15 -22

3.3 Fundamental Score

Let's check the fundamental score of Cathay Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1564.318
Price to Book Ratio (EOD)Between0-11.677
Net Profit Margin (MRQ)Greater than00.127
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.132
Current Ratio (MRQ)Greater than12.869
Debt to Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.293
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.005
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cathay Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.059
Ma 20Greater thanMa 5040.265
Ma 50Greater thanMa 10042.017
Ma 100Greater thanMa 20042.749
OpenGreater thanClose42.670
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Cathay Biotech Inc

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech Inc. was incorporated in 2000 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2025-01-25 01:21:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cathay Biotech Inc earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • A Net Profit Margin of 12.7% means that ¥0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cathay Biotech Inc:

  • The MRQ is 12.7%. The company is making a huge profit. +2
  • The TTM is 14.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.7%TTM14.1%-1.4%
TTM14.1%YOY17.8%-3.7%
TTM14.1%5Y18.8%-4.7%
5Y18.8%10Y18.8%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.7%2.2%+10.5%
TTM14.1%2.3%+11.8%
YOY17.8%4.3%+13.5%
5Y18.8%4.8%+14.0%
10Y18.8%5.2%+13.6%
4.3.1.2. Return on Assets

Shows how efficient Cathay Biotech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • 0.5% Return on Assets means that Cathay Biotech Inc generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cathay Biotech Inc:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.5%0.0%
TTM0.5%YOY0.5%+0.0%
TTM0.5%5Y0.6%-0.1%
5Y0.6%10Y0.6%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%0.6%-0.1%
TTM0.5%0.6%-0.1%
YOY0.5%1.1%-0.6%
5Y0.6%1.3%-0.7%
10Y0.6%1.4%-0.8%
4.3.1.3. Return on Equity

Shows how efficient Cathay Biotech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • 0.9% Return on Equity means Cathay Biotech Inc generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cathay Biotech Inc:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.9%0.0%
TTM0.9%YOY0.9%+0.0%
TTM0.9%5Y1.0%-0.2%
5Y1.0%10Y1.0%0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%1.2%-0.3%
TTM0.9%1.3%-0.4%
YOY0.9%2.0%-1.1%
5Y1.0%2.6%-1.6%
10Y1.0%2.5%-1.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cathay Biotech Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cathay Biotech Inc is operating .

  • Measures how much profit Cathay Biotech Inc makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cathay Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.8%-5.8%
TTM-4.2%-4.2%
YOY-4.8%-4.8%
5Y-6.0%-6.0%
10Y-6.3%-6.3%
4.3.2.2. Operating Ratio

Measures how efficient Cathay Biotech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ¥1.49 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Cathay Biotech Inc:

  • The MRQ is 1.485. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.533. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.485TTM1.533-0.047
TTM1.533YOY1.561-0.028
TTM1.5335Y1.520+0.013
5Y1.52010Y1.5200.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4851.713-0.228
TTM1.5331.672-0.139
YOY1.5611.620-0.059
5Y1.5201.570-0.050
10Y1.5201.313+0.207
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cathay Biotech Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cathay Biotech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 2.87 means the company has ¥2.87 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Cathay Biotech Inc:

  • The MRQ is 2.869. The company is able to pay all its short-term debts. +1
  • The TTM is 2.617. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.869TTM2.617+0.252
TTM2.617YOY4.194-1.577
TTM2.6175Y4.977-2.359
5Y4.97710Y4.9770.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8691.492+1.377
TTM2.6171.556+1.061
YOY4.1941.631+2.563
5Y4.9771.755+3.222
10Y4.9771.663+3.314
4.4.3.2. Quick Ratio

Measures if Cathay Biotech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • A Quick Ratio of 0.13 means the company can pay off ¥0.13 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cathay Biotech Inc:

  • The MRQ is 0.132. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.109. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.109+0.024
TTM0.109YOY0.170-0.062
TTM0.1095Y0.190-0.081
5Y0.19010Y0.1900.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1320.557-0.425
TTM0.1090.624-0.515
YOY0.1700.759-0.589
5Y0.1900.851-0.661
10Y0.1900.876-0.686
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cathay Biotech Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cathay Biotech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cathay Biotech Inc to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.18 means that Cathay Biotech Inc assets are financed with 18.2% credit (debt) and the remaining percentage (100% - 18.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cathay Biotech Inc:

  • The MRQ is 0.182. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.197. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.197-0.014
TTM0.197YOY0.173+0.024
TTM0.1975Y0.165+0.031
5Y0.16510Y0.1650.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.436-0.254
TTM0.1970.436-0.239
YOY0.1730.416-0.243
5Y0.1650.416-0.251
10Y0.1650.406-0.241
4.5.4.2. Debt to Equity Ratio

Measures if Cathay Biotech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • A Debt to Equity ratio of 29.3% means that company has ¥0.29 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cathay Biotech Inc:

  • The MRQ is 0.293. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.324. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.293TTM0.324-0.030
TTM0.324YOY0.287+0.036
TTM0.3245Y0.270+0.053
5Y0.27010Y0.2700.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2930.795-0.502
TTM0.3240.807-0.483
YOY0.2870.749-0.462
5Y0.2700.778-0.508
10Y0.2700.820-0.550
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Cathay Biotech Inc generates.

  • Above 15 is considered overpriced but always compare Cathay Biotech Inc to the Chemicals industry mean.
  • A PE ratio of 70.94 means the investor is paying ¥70.94 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cathay Biotech Inc:

  • The EOD is 64.318. Based on the earnings, the company is expensive. -2
  • The MRQ is 70.944. Based on the earnings, the company is expensive. -2
  • The TTM is 82.748. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD64.318MRQ70.944-6.626
MRQ70.944TTM82.748-11.804
TTM82.748YOY112.896-30.149
TTM82.7485Y93.909-11.161
5Y93.90910Y93.9090.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD64.31813.191+51.127
MRQ70.94413.772+57.172
TTM82.74812.100+70.648
YOY112.89613.822+99.074
5Y93.90915.570+78.339
10Y93.90922.288+71.621
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cathay Biotech Inc:

  • The EOD is 38.975. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 42.990. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 7.615. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD38.975MRQ42.990-4.015
MRQ42.990TTM7.615+35.375
TTM7.615YOY-77.094+84.709
TTM7.6155Y-29.409+37.024
5Y-29.40910Y-29.4090.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD38.9751.477+37.498
MRQ42.9901.751+41.239
TTM7.6150.463+7.152
YOY-77.0940.178-77.272
5Y-29.4090.782-30.191
10Y-29.4091.651-31.060
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cathay Biotech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 1.85 means the investor is paying ¥1.85 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Cathay Biotech Inc:

  • The EOD is 1.677. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.850. Based on the equity, the company is underpriced. +1
  • The TTM is 1.883. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.677MRQ1.850-0.173
MRQ1.850TTM1.883-0.033
TTM1.883YOY2.318-0.435
TTM1.8835Y2.529-0.646
5Y2.52910Y2.5290.000
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD1.6771.327+0.350
MRQ1.8501.396+0.454
TTM1.8831.380+0.503
YOY2.3181.565+0.753
5Y2.5291.750+0.779
10Y2.5292.177+0.352
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets18,330,036
Total Liabilities3,340,852
Total Stockholder Equity11,386,757
 As reported
Total Liabilities 3,340,852
Total Stockholder Equity+ 11,386,757
Total Assets = 18,330,036

Assets

Total Assets18,330,036
Total Current Assets6,812,364
Long-term Assets11,517,672
Total Current Assets
Cash And Cash Equivalents 4,637,141
Short-term Investments 469
Net Receivables 313,529
Inventory 1,273,812
Other Current Assets 319,727
Total Current Assets  (as reported)6,812,364
Total Current Assets  (calculated)6,544,678
+/- 267,686
Long-term Assets
Property Plant Equipment 9,735,590
Intangible Assets 689,208
Long-term Assets Other 770,877
Long-term Assets  (as reported)11,517,672
Long-term Assets  (calculated)11,195,675
+/- 321,997

Liabilities & Shareholders' Equity

Total Current Liabilities2,374,106
Long-term Liabilities966,746
Total Stockholder Equity11,386,757
Total Current Liabilities
Short Long Term Debt 691,283
Accounts payable 1,492,527
Other Current Liabilities 7,483
Total Current Liabilities  (as reported)2,374,106
Total Current Liabilities  (calculated)2,191,292
+/- 182,814
Long-term Liabilities
Long term Debt 572,015
Long-term Liabilities  (as reported)966,746
Long-term Liabilities  (calculated)572,015
+/- 394,730
Total Stockholder Equity
Retained Earnings 2,303,327
Total Stockholder Equity (as reported)11,386,757
Total Stockholder Equity (calculated)2,303,327
+/- 9,083,431
Other
Capital Stock583,378
Common Stock Shares Outstanding 583,378
Net Invested Capital 12,650,055
Net Working Capital 4,438,258
Property Plant and Equipment Gross 9,735,590



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
16,421,778
16,678,950
17,286,724
17,827,281
18,199,553
18,492,896
18,797,751
18,833,373
18,617,744
18,322,692
18,330,036
18,330,03618,322,69218,617,74418,833,37318,797,75118,492,89618,199,55317,827,28117,286,72416,678,95016,421,778
   > Total Current Assets 
10,665,454
9,800,299
9,098,438
8,475,499
8,273,543
8,425,898
8,039,355
7,570,668
7,151,483
6,827,315
6,812,364
6,812,3646,827,3157,151,4837,570,6688,039,3558,425,8988,273,5438,475,4999,098,4389,800,29910,665,454
       Cash And Cash Equivalents 
8,633,895
7,870,359
6,949,642
6,294,604
6,089,119
6,166,817
5,819,930
5,390,218
4,987,762
4,634,914
4,637,141
4,637,1414,634,9144,987,7625,390,2185,819,9306,166,8176,089,1196,294,6046,949,6427,870,3598,633,895
       Short-term Investments 
469
469
469
469
469
469
469
469
469
469
469
469469469469469469469469469469469
       Net Receivables 
362,020
325,585
364,871
390,401
338,723
267,519
307,951
243,256
291,690
305,480
313,529
313,529305,480291,690243,256307,951267,519338,723390,401364,871325,585362,020
       Inventory 
1,280,900
1,407,118
1,564,319
1,573,638
1,557,075
1,491,381
1,513,748
1,466,356
1,374,593
1,328,845
1,273,812
1,273,8121,328,8451,374,5931,466,3561,513,7481,491,3811,557,0751,573,6381,564,3191,407,1181,280,900
       Other Current Assets 
257,284
42,578
41,833
80,921
118,342
189,151
237,883
287,224
289,854
298,879
319,727
319,727298,879289,854287,224237,883189,151118,34280,92141,83342,578257,284
   > Long-term Assets 
5,756,324
6,878,651
8,188,285
9,351,782
9,926,010
10,066,998
10,758,397
11,262,705
11,466,261
11,495,377
11,517,672
11,517,67211,495,37711,466,26111,262,70510,758,39710,066,9989,926,0109,351,7828,188,2856,878,6515,756,324
       Property Plant Equipment 
0
0
0
6,669,851
7,206,772
7,659,402
8,571,551
9,375,786
9,541,645
9,651,090
9,735,590
9,735,5909,651,0909,541,6459,375,7868,571,5517,659,4027,206,7726,669,851000
       Intangible Assets 
763,971
759,498
781,842
777,875
794,235
708,029
703,173
703,854
698,840
694,279
689,208
689,208694,279698,840703,854703,173708,029794,235777,875781,842759,498763,971
       Long-term Assets Other 
826,277
1,583,138
1,733,462
1,759,099
1,674,634
1,381,921
1,154,424
876,479
909,259
831,352
770,877
770,877831,352909,259876,4791,154,4241,381,9211,674,6341,759,0991,733,4621,583,138826,277
> Total Liabilities 
1,539,580
1,854,018
2,332,312
2,789,068
3,085,298
3,298,422
3,531,009
4,060,263
3,753,844
3,432,103
3,340,852
3,340,8523,432,1033,753,8444,060,2633,531,0093,298,4223,085,2982,789,0682,332,3121,854,0181,539,580
   > Total Current Liabilities 
1,022,117
1,040,780
1,189,664
1,424,183
1,699,732
2,650,541
2,894,892
3,409,753
2,753,664
2,454,447
2,374,106
2,374,1062,454,4472,753,6643,409,7532,894,8922,650,5411,699,7321,424,1831,189,6641,040,7801,022,117
       Short Long Term Debt 
492,595
257,076
275,566
166,848
431,920
1,213,247
1,258,563
1,530,623
1,085,270
733,675
691,283
691,283733,6751,085,2701,530,6231,258,5631,213,247431,920166,848275,566257,076492,595
       Accounts payable 
333,907
379,742
691,273
1,060,056
1,110,574
1,170,560
1,469,871
1,681,950
1,448,608
1,475,740
1,492,527
1,492,5271,475,7401,448,6081,681,9501,469,8711,170,5601,110,5741,060,056691,273379,742333,907
       Other Current Liabilities 
2,616
1,626
2,443
2,160
2,044
2,375
2,234
5,861
4,648
7,216
7,483
7,4837,2164,6485,8612,2342,3752,0442,1602,4431,6262,616
   > Long-term Liabilities 
517,462
813,238
1,142,647
1,364,885
1,385,566
647,881
636,117
650,510
1,000,180
977,656
966,746
966,746977,6561,000,180650,510636,117647,8811,385,5661,364,8851,142,647813,238517,462
       Long term Debt 
230,000
530,272
730,248
960,500
985,500
251,000
244,540
245,332
597,589
577,509
572,015
572,015577,509597,589245,332244,540251,000985,500960,500730,248530,272230,000
> Total Stockholder Equity
10,842,937
10,764,582
10,881,328
10,948,955
11,010,586
11,082,092
11,137,776
11,164,181
11,253,239
11,284,837
11,386,757
11,386,75711,284,83711,253,23911,164,18111,137,77611,082,09211,010,58610,948,95510,881,32810,764,58210,842,937
   Common Stock00000000000
   Retained Earnings 
1,634,932
1,596,363
1,746,091
1,807,249
1,864,691
1,944,321
2,016,348
2,068,601
2,173,860
2,205,595
2,303,327
2,303,3272,205,5952,173,8602,068,6012,016,3481,944,3211,864,6911,807,2491,746,0911,596,3631,634,932
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 00000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,114,175
Cost of Revenue-1,505,425
Gross Profit608,750608,750
 
Operating Income (+$)
Gross Profit608,750
Operating Expense-1,840,830
Operating Income273,345-1,232,080
 
Operating Expense (+$)
Research Development189,128
Selling General Administrative103,023
Selling And Marketing Expenses0
Operating Expense1,840,830292,151
 
Net Interest Income (+$)
Interest Income219,771
Interest Expense-32,172
Other Finance Cost-5,701
Net Interest Income181,898
 
Pretax Income (+$)
Operating Income273,345
Net Interest Income181,898
Other Non-Operating Income Expenses0
Income Before Tax (EBT)448,925273,345
EBIT - interestExpense = -32,172
366,524
398,696
Interest Expense32,172
Earnings Before Interest and Taxes (EBIT)0481,096
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax448,925
Tax Provision-40,389
Net Income From Continuing Ops408,536408,536
Net Income366,524
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-181,898
 

Technical Analysis of Cathay Biotech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cathay Biotech Inc. The general trend of Cathay Biotech Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cathay Biotech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cathay Biotech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 46.98 < 55.50 < 56.98.

The bearish price targets are: 40.86 > 36.81 > 36.69.

Tweet this
Cathay Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cathay Biotech Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cathay Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cathay Biotech Inc. The current macd is 0.56835981.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cathay Biotech Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cathay Biotech Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cathay Biotech Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cathay Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartCathay Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cathay Biotech Inc. The current adx is 26.78.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cathay Biotech Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Cathay Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cathay Biotech Inc. The current sar is 41.92.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cathay Biotech Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cathay Biotech Inc. The current rsi is 60.06. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Cathay Biotech Inc Daily Relative Strength Index (RSI) ChartCathay Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cathay Biotech Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cathay Biotech Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cathay Biotech Inc Daily Stochastic Oscillator ChartCathay Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cathay Biotech Inc. The current cci is 87.05.

Cathay Biotech Inc Daily Commodity Channel Index (CCI) ChartCathay Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cathay Biotech Inc. The current cmo is 29.30.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cathay Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartCathay Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cathay Biotech Inc. The current willr is -20.13071895.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cathay Biotech Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cathay Biotech Inc Daily Williams %R ChartCathay Biotech Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cathay Biotech Inc.

Cathay Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cathay Biotech Inc. The current atr is 1.36199376.

Cathay Biotech Inc Daily Average True Range (ATR) ChartCathay Biotech Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cathay Biotech Inc. The current obv is -16,091,418.

Cathay Biotech Inc Daily On-Balance Volume (OBV) ChartCathay Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cathay Biotech Inc. The current mfi is 68.24.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cathay Biotech Inc Daily Money Flow Index (MFI) ChartCathay Biotech Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cathay Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Cathay Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cathay Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.059
Ma 20Greater thanMa 5040.265
Ma 50Greater thanMa 10042.017
Ma 100Greater thanMa 20042.749
OpenGreater thanClose42.670
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cathay Biotech Inc with someone you think should read this too:
  • Are you bullish or bearish on Cathay Biotech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cathay Biotech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cathay Biotech Inc

I send you an email if I find something interesting about Cathay Biotech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cathay Biotech Inc.

Receive notifications about Cathay Biotech Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.